Effects of vitamin D and retinoic acid on human glioblastoma cell lines
- 127 Downloads
The biological significance of vitamin D receptors expressed by glioblastoma and other glial tumours is still unclear. In an effort to clarify this issue we studied the effects of increasing concentrations of 25-dihydroxyvitamin D3 and its metabolite 1 α, 25-dihydroxyvitamin D3 on two human glioblastoma cell lines. Both substances were capable of inducing a significant (> 50%) reduction in growth of the two glioblastoma cell lines at dosages over 5 μM. When the HU 70 cell line was treated by increasing dilutions of 25-dihydroxyvitamin D3 combined with 1 μM all trans-retinoic acid, significant inhibition was apparent even after addition of 25-dihydroxyvitamin D3 in the nanomolar range. Reduction of growth index was mainly due to induced cell death.
Our results providein vitro evidence that vitamin D metabolites alone or in combination with retinoids may be potentially useful agents in the differentiation therapy of human malignant gliomas.
KeywordsGlioblastoma retinoic acid vitamin D cell death
Unable to display preview. Download preview PDF.
- 9.Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (1974) Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 33: 191–306Google Scholar
- 11.Della Valle G, Talarico D, Fognani C, Peverali AF, Raimondi E, De Carli L, Gerosa M (1989) Oncogene expression in human brain tumors. In: Broggi G, Gerosa MA (eds) Cerebral gliomas. Excerpta Medica, Amsterdam, pp 23–30Google Scholar
- 15.Gerosa MA, Talarico D, Fognani C, Raimondi E, Colombatti M, Tridente G, De Carli L, Della Valle G (1989) Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. J Natl Canc Inst 81: 63–67Google Scholar
- 16.Hanauske A-R (1993) New approaches to chemotherapy of brain tumors with or without radiation. Crit Rev Neurosurg 3: 45–49Google Scholar
- 19.Langer A, Verjans H, Stapor V, Mol M, Fraczykowska M (1993) Topical calcitriol in the treatment of chronic plaque psoriasis: a double blind study. Br J Derm 128: 566–571Google Scholar
- 23.Matsumoto K, Azuma Y, Kiyoki M, Okumura H, Hashimoto K, Yoshikawa K (1991) Involvement of endogenously produced 1,25-dihydroxyvitamin D3 in the growth and differentiation of human keratinocytes. Biochem Biophys Ac 1092: 311–318Google Scholar
- 26.Noda M, Voge L, Craig AM, Prahl J, DeLuca H, Denhardt DT (1990) Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin d 3 receptor and 1,25-dihydroxyvitamin d 3 enhancement of mouse secreted phosphoprotein I (Spp-1 or osteopontine) gene expression. Proc Natl Acad Sci USA 87: 9995–9999PubMedGoogle Scholar
- 27.Okabe-Kado J, Honma Y, Kasukabe T, Hozumi M (1993) Synthesis of active metabolites from alpha-hydroxyvitamin D3 by human monocytic leukemia cells. FEBS-Lett 309: 399–401Google Scholar
- 28.Paoletti P, Walker MD, Takakura K, Butti G, Pezzotta S (eds) (1991) Neuro-Oncology. Kluwer, DordrechtGoogle Scholar
- 33.Schwartz Z, Brooks B, Swain L, Del Toro F, Norman A, Boyan B (1992) Production of 1,25-dihydroxyvitamin D3 and 24,25- dihydroxyvitamin D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology 130: 2495–2504PubMedGoogle Scholar
- 35.Shany S, Ren SY, Arbelle JE, Clemens TL, Adams JS (1993) Subcellular localization and partial purification of the 25-hydroxyvitamin D3 1-hydroxilation reaction in the chick myelomonocytic cell line HD-11. J Bone Min Res 8: 269–276Google Scholar
- 39.Walters MA (1992) Newly identified actions of the vitamin D endocrine system. Endocrin Rev 13: 719–764Google Scholar
- 42.Yung WKA, Simaga M, Levin VA (1993) 13-cis-retinoic acid: a new and potentially effective agent for recurrent malignant astrocytomas. ASCO Proc 12: 175Google Scholar